Advancing Drug Development with Real World Data | Healthcare In Action Abbreviated

The future of drug development is being reshaped by real world evidence, and TargetRWE is at the center of that transformation. In this episode, Jon Lange sits down with Ed Seguine, CEO of Target RWE and co-founder of Clinical Ink, to unpack how technology, structured data, and clinician insights are accelerating clinical trials and changing how we understand complex diseases. From unlocking the untapped value of messy EMR data to addressing ethical concerns, Ed shares how real world data can reduce trial costs, shorten timelines, and lead to better outcomes for patients. This episode is an abbreviated version of the original Healthcare In Action conversation (Season 1 Episode 7).